耐药结核病的耐药机制及治疗研究进展
Research progress on drug resistance mechanism and treatment of drug-resistant tuberculosis
钟珊珊 1彭昱 1毛蓉容 2王芳 1樊思桐 1陈佳佳3
作者信息
- 1. 浙江大学医学院附属第一医院北仑分院(宁波市北仑区人民医院)感染科,浙江宁波315800
- 2. 浙江大学医学院附属第一医院北仑分院(宁波市北仑区人民医院)门诊部,浙江宁波315800
- 3. 浙江大学医学院附属第一医院感染科,杭州 310003
- 折叠
摘要
结核病由结核分枝杆菌引发,其耐药性问题近年来日益凸显,在全球范围内受到广泛关注.目前,耐药结核病的防治形势严峻,亟需采取有效策略应对.了解耐药结核病的耐药机制和治疗现状可为临床防治耐药结核病提供重要依据,现就耐药结核病的耐药机制及治疗研究进展进行综述,以期为临床提供借鉴.
Abstract
Tuberculosis is caused by Mycobacterium tuberculosis,and the problem of its drug resistance has become increasingly prominent in recent years,attracting widespread attention globally.Currently,the situation of drug-resistant tuberculosis is grim,and effective strategies are urgently needed to deal with it.Understanding the drug resistance mechanism and treatment status of drug-resistant tuberculosis can provide an important basis for clinical prevention and treatment of drug-resistant tuberculosis.This paper reviews the progress of drug resistance mechanism and treatment of drug-resistant tuberculosis,in order to provide a reference for clinical intervention.
关键词
耐药结核病/耐药机制/治疗/研究进展/结核分枝杆菌Key words
Drug-resistant tuberculosis/Mechanisms of drug resistance/Treatment/Research progress/Mycobacterium tuberculosis引用本文复制引用
出版年
2024
NETL
NSTL
万方数据